We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$237M
AUM Growth
+$55.9M
Cap. Flow
+$50.9M
Cap. Flow %
21.44%
Top 10 Hldgs %
68.51%
Holding
729
New
76
Increased
83
Reduced
120
Closed
343

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.93M
2
EFOR
Everforth Inc
EFOR
+$1.81M
3
F icon
Ford
F
+$1.74M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$1.05M
5
XYL icon
Xylem
XYL
+$747K

Sector Composition

Rank Sector Weight
1 Financials 23.74%
2 Consumer Discretionary 10.93%
3 Technology 10.32%
4 Healthcare 4.2%
5 Industrials 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
326
TJX Companies
TJX
$179B
$9K ﹤0.01%
250
-56
-18% -$2.11K
UAA icon
327
Under Armour
UAA
$3.01B
$9K ﹤0.01%
400
CMRX
328
DELISTED
Chimerix, Inc.
CMRX
$9K ﹤0.01%
1,600
ERF
329
DELISTED
Enerplus Corporation
ERF
$9K ﹤0.01%
1,050
SBNY
330
DELISTED
Signature Bank
SBNY
$9K ﹤0.01%
60
CHRD icon
331
Chord Energy
CHRD
$7.68B
$8K ﹤0.01%
1,000
DHR icon
332
Danaher
DHR
$138B
$8K ﹤0.01%
113
-27
-19% -$2.02K
UA icon
333
Under Armour Class C
UA
$2.95B
$8K ﹤0.01%
402
-500
-55% -$9.42K
XYZ
334
Block Inc
XYZ
$48.9B
$8K ﹤0.01%
327
WFT
335
DELISTED
Weatherford International plc
WFT
$8K ﹤0.01%
2,000
GM icon
336
General Motors
GM
$80.9B
$7K ﹤0.01%
204
-51
-20% -$1.73K
SBGI icon
337
Sinclair Inc
SBGI
$1.02B
$7K ﹤0.01%
200
XIV
338
DELISTED
VelocityShares Daily Inverse VIX Short Term ETN
XIV
$7K ﹤0.01%
80
NVAX icon
339
Novavax
NVAX
$1.21B
$6K ﹤0.01%
250
VWO icon
340
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$5K ﹤0.01%
115
-135
-54% -$5.47K
BIVV
341
DELISTED
Bioverativ Inc. Common Stock
BIVV
$5K ﹤0.01%
83
-2
-2% -$114
PRGO icon
342
Perrigo
PRGO
$1.44B
$4K ﹤0.01%
55
-4
-7% -$287
SCHX icon
343
Schwab US Large- Cap ETF
SCHX
$70.3B
$4K ﹤0.01%
450
-13,386
-97% -$128K
CARB
344
DELISTED
Carbonite Inc
CARB
$4K ﹤0.01%
175
C icon
345
Citigroup
C
$213B
$3K ﹤0.01%
38
-164
-81% -$10.1K
CCRN
346
DELISTED
Cross Country Healthcare
CCRN
$3K ﹤0.01%
200
FTV icon
347
Fortive
FTV
$18.2B
$3K ﹤0.01%
79
-19
-19% -$748
GERN icon
348
Geron
GERN
$898M
$3K ﹤0.01%
1,000
HON icon
349
Honeywell
HON
$76.4B
$3K ﹤0.01%
24
-70
-74% -$8.26K
HYG icon
350
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$3K ﹤0.01%
39

Similar funds

Pathstone Family Office's Q2 2017 Portfolio in Review

As of Q2 2017, Pathstone Family Office held 729 positions worth $237M, up 31% from $181M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Pathstone Family Office deployed $50.9M of net new capital in Q2 2017, opening 76 new positions and adding to 83 existing holdings. Its largest new stake was iShares Core High Dividend ETF: 233,470 shares worth $3.88M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.93M trimmed.

  • Pathstone Family Office's largest Q2 2017 buy was iShares Core High Dividend ETF: 233,470 shares worth $3.88M.
  • Pathstone Family Office added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $18.4M increase.
  • Pathstone Family Office's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $3.93M.
  • Pathstone Family Office fully exited Ford in Q2 2017, selling an estimated $1.74M.
  • Pathstone Family Office's ten largest holdings make up 69% of its $237M portfolio in Q2 2017.
  • Pathstone Family Office opened 76 new positions and closed 343 in Q2 2017.
  • Pathstone Family Office's portfolio value rose 31% quarter-over-quarter to $237M.

Based on Pathstone Family Office's 13F filing for Q2 2017, filed 11 Aug 2017.